Back to mobile site

RBC Capital Downgrades Rigel Pharmaceuticals (RIGL) to Underperform

January 30, 2009 8:11 AM EST Send to a Friend
RBC Capital downgrades Rigel Pharmaceuticals (Nasdaq: RIGL) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login